Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Quick Answer: Tirzepatide causes therapeutic, reversible slowing of gastric emptying but has not been established to cause gastroparesis as a pathological condition
If they worsen or begin interfering with daily activities, that warrants a conversation about dose adjustment
, ,
For complete documentation checklists and PA preparation: Zepbound Prior Authorization Guide YOUR PLAN COVERS IT If Your PA Was Denied If Your PA Was Denied Your plan covers Zepbound, but the prior authorization was rejected
Kishimori T et al
Self-injection in this location may result in improper technique or inadvertent intramuscular injection if adequate subcutaneous tissue is not accessed
US$ 26.70
US$ 23.78
US$ 27.61
US$ 28.36
US$ 23.84
US$ 22.51
US$ 29.37
US$ 24.18
US$ 28.69
